Key Insights

Highlights

Success Rate

90% trial completion (above average)

Published Results

261 trials with published results (20%)

Research Maturity

739 completed trials (56% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

6.4%

85 terminated out of 1320 trials

Success Rate

89.7%

+3.2% vs benchmark

Late-Stage Pipeline

19%

247 trials in Phase 3/4

Results Transparency

35%

261 of 739 completed with results

Key Signals

261 with results90% success85 terminated

Data Visualizations

Phase Distribution

915Total
Not Applicable (428)
Early P 1 (13)
P 1 (110)
P 2 (117)
P 3 (156)
P 4 (91)

Trial Status

Completed739
Unknown180
Recruiting171
Terminated85
Not Yet Recruiting51
Withdrawn37

Trial Success Rate

89.7%

Benchmark: 86.5%

Based on 739 completed trials

Clinical Trials (1320)

Showing 20 of 20 trials
NCT06213090Recruiting

Patterns of Neurodevelopmental Disorders

NCT04694313Not ApplicableCompletedPrimary

Evaluation of Optical Pumping Magnetometer Sensors for MagnetoEncephaloGraphy Imaging

NCT02886650Not ApplicableCompletedPrimary

Impact of Thermocoagulation During Invasive EEG Monitoring in Children With Focal Drug-resistant Epilepsies

NCT07527754Not Yet RecruitingPrimary

S100B Protein: a Diagnostic Aid in Episodes of Transient Loss of Consciousness?

NCT07519018Not ApplicableNot Yet RecruitingPrimary

TIS for Drug Resistant TLE

NCT01345058Phase 3CompletedPrimary

Add on Lacosamide Versus High Dose Monotherapy

NCT02107989RecruitingPrimary

Noninvasive Pre-surgical Evaluation of Patients With Focal Epilepsy and Establishment of a Normative Imaging Database

NCT06736002Not ApplicableRecruitingPrimary

Effects of Mega-dose Vitamin D Pulse and Maintenance Therapy on Seizure Frequency, Fatigue, and Quality of Life: A Prospective Study

NCT07520955Not ApplicableNot Yet RecruitingPrimary

Lily's Grace Temporal Interference

NCT04999046Not ApplicableCompleted

NaviFUS™ System Neuromodulating Treatment for Patients With Drug Resistant Epilepsy

NCT06492720Not ApplicableRecruiting

A Pilot Study to Evaluate the Efficacy and Safety of NaviFUS™ System Neuromodulating Treatment for Patients With Drug Resistant Epilepsy

NCT06388707Phase 1Recruiting

A Safety, Tolerability, and Preliminary Efficacy of Low-intensity Focused Ultrasound Neuromodulation in Patients With Drug-resistant Epilepsy

NCT07228338Early Phase 1Not Yet RecruitingPrimary

Cholinergic Enhancement of Theta

NCT05290610Not ApplicableRecruitingPrimary

Intracranial Stimulation Mapping In Epilepsy

NCT02403843CompletedPrimary

RNS® System Epilepsy Post-Approval Study

NCT07010445Not ApplicableRecruiting

MiCrobiota-gut-brain Axis in Resistant Epilepsy

NCT07110337Not ApplicableRecruitingPrimary

Diagnosing Epilepsy To EffeCT Change

NCT07110454RecruitingPrimary

Diagnosing Epilepsy To EffeCT Change Long-Term Follow-Up

NCT04770337Not ApplicableCompleted

Pivotal-Safety and Therapeutic Measures of tDCS in Patients With Refractory Focal Epilepsy

NCT07509177Not ApplicableRecruitingPrimary

An Examination of Whether Infrared Light Therapy Can Reduce Stress in People With Epilepsy

Scroll to load more

Research Network

Activity Timeline